Haite Biotech: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Haite Biotech: SDIC Securities Co., Ltd.\'s 2024 semi-annual regular on-site inspection report on the company\'s continuous supervision work
Haite Biotech: SDIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report
Haite Biotech: Announcement on obtaining a registration certificate for injectable esomeprazole sodium drugs
Haite Biotech: SDIC Securities Co., Ltd.\'s inspection opinion on the extension of some of the company\'s fund-raising investment projects
Haite Biotech: 2024 Semi-Annual Report Summary
Haite Biotech: Summary table on the use of non-operating funds and other related capital transactions for the first half year of 2024
Haite Biotech: Announcement of Supervisory Board Resolutions
Haite Biotech: Announcement on the extension of some fund-raising investment projects
Haite Biotech: Announcement of Board Resolutions
Haite Biotech: Prompt Announcement on 2024 Semi-Annual Report and Summary Disclosure
Haite Biotech: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Haite Biotech: 2024 Semi-Annual Report
Wuhan Hiteck Biological Pharma: Progress Announcement on the Use of Surplus Self-Owned Funds to Purchase Wealth Management Products
Wuhan Hiteck Biological Pharma: Announcement on the Progress of Using Idle Proprietary Funds and Raised Funds to Purchase Financial Products.
Wuhan Hiteck Biological Pharma: Announcement Regarding the Plan of Introducing External Investors for Capital Increase in Wholly-owned Subsidiary.
Wuhan Hiteck Biological Pharma: Announcement of Resolutions of the Sixteenth Meeting of the Eighth Board of Directors.
Wuhan Hiteck Biological Pharma: Announcement of the Resolution of the Sixteenth Meeting of the Eighth Supervisory Board.
Wuhan Hiteck Biological Pharma: Notice on obtaining a drug registration certificate for injectable roxatidine hydrochloride acetate
Wuhan Hiteck Biological Pharma: Announcement on pledged repurchase transactions of some shares of the controlling shareholder
No Data
No Data